High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.
Publication
, Journal Article
Steuber, CP; Fernbach, DJ; Starling, KA; Falletta, JM
Published in: Cancer Chemother Rep
1974
Published In
Cancer Chemother Rep
ISSN
0069-0112
Publication Date
1974
Volume
58
Issue
3
Start / End Page
417 / 419
Location
United States
Related Subject Headings
- Time Factors
- Leukocyte Count
- Leukemia, Myeloid
- Leukemia, Lymphoid
- Leukemia
- Humans
- Cyclophosphamide
- Clinical Trials as Topic
- Child, Preschool
- Child
Citation
APA
Chicago
ICMJE
MLA
NLM
Steuber, C. P., Fernbach, D. J., Starling, K. A., & Falletta, J. M. (1974). High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep, 58(3), 417–419.
Steuber, C. P., D. J. Fernbach, K. A. Starling, and J. M. Falletta. “High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.” Cancer Chemother Rep 58, no. 3 (1974): 417–19.
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep. 1974;58(3):417–9.
Steuber, C. P., et al. “High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.” Cancer Chemother Rep, vol. 58, no. 3, 1974, pp. 417–19.
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep. 1974;58(3):417–419.
Published In
Cancer Chemother Rep
ISSN
0069-0112
Publication Date
1974
Volume
58
Issue
3
Start / End Page
417 / 419
Location
United States
Related Subject Headings
- Time Factors
- Leukocyte Count
- Leukemia, Myeloid
- Leukemia, Lymphoid
- Leukemia
- Humans
- Cyclophosphamide
- Clinical Trials as Topic
- Child, Preschool
- Child